Increased catalytic activity of PR3 in COPD results in a high catalytic turnover of elastin in pulmonary parenchyma in relation to impaired lung elasticity and emphysema (Gudmann et al., 2018). The gene discussed is PRTN3; the disease is chronic obstructive pulmonary disease.